Tadalafil Tablet, Film Coated
Product Images NDC 71205-268

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71205-268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Tadalafil Figure1)

Figure (Tadalafil Figure1)
The text seems to be a table showing the difference in blood pressure (measured in mmHg) between a group taking Tadalafil and a group taking Placebo. The table includes measurements for both standing and supine positions, as well as over a period of time (in hours). The text is not sufficient to provide further information.*
FDA Label Image

Figure (Tadalafil Figure2)

Figure (Tadalafil Figure2)
The text appears to be a combination of numerical values and some errors. The only useful information that can be extracted from the text is the title "Tadalafil 20mg & Doxazosin 8mg" along with a graph showing the effects of the medication over time. The rest of the text is either numerical data or errors, rendering it not usable.*
FDA Label Image

Figure (Tadalafil Figure3)

Figure (Tadalafil Figure3)
FDA Label Image

Figure (Tadalafil Figure4)

Figure (Tadalafil Figure4)
This is a graph displaying Plasma Tadalafil Concentration (in µg/L) over time (in hours) after administering different doses of Tadalafil. It shows the concentration for a single 20-mg dose, a single 5-mg dose, and a once-daily 5-mg dose following 5 consecutive days of administration. The concentration of Tadalafil decreases with time.*
FDA Label Image

Figure 5 (Tadalafil Figure5)

Figure 5 (Tadalafil Figure5)
The text provides information about the change from baseline in the IPSS total score of a medication called "tadalafils" compared to a placebo. The results show a statistically significant improvement in the IPSS total score for tadalafils compared to placebo (p<0.01) after 12 weeks of treatment.*
FDA Label Image

Figure 6 (Tadalafil Figure6)

Figure 6 (Tadalafil Figure6)
FDA Label Image

Figure 7 (Tadalafil Figure7)

Figure 7 (Tadalafil Figure7)
FDA Label Image

Figure 8 (Tadalafil Figure8)

Figure 8 (Tadalafil Figure8)
FDA Label Image

71205-268-30 (Tadalafil Label 20mg)

71205-268-30 (Tadalafil Label 20mg)
This is a description of Tadalafil 20mg tablets with product ID QT026810. The tablets are yellow in color, almond-shaped, film-coated, and contain 20mg of Tadalafil USP per tablet. The tablets are embossed with "FJ4" on one side and plain on the other side. The tablets are packaged by Profcent Rx LP in Thousand Oaks, CA 81320. There are three different lots mentioned in this description, each with 10 tablets, labeled SNEMASTER, SN#MASTER, and SNAMASTER, with expiry date 00/00/00 and lot number 00000. The tablets are manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India, and are RX Only. The NDC for the tablets is 71205-268-10 and the GTIN is 00371205268107. This medicine should be kept out of the reach of children and stored at 25°C (77°F).*
FDA Label Image

Chemical Structure (Tadalafil Structure)

Chemical Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.